Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alicja Puszkiel, Gaëlle Noé, Audrey Thomas-Schoemann, Audrey Bellesoeur, Pascaline Boudou-Rouquette, Michel Vidal, François Goldwasser & Benoit Blanchet. (2017) Pharmacokinetics and Pharmacodynamics of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma. International Journal of Pharmacokinetics 2:4, pages 257-283.
Read now
Read now
Bo Sun, Yankun Guo, Junwei Gao, Weifeng Shi, Guorong Fan, Xiaoyu Li, Jianxin Qiu, Yan Qin & Gaolin Liu. (2017) Influence of CYP3A and ABCB1 Polymorphisms on Cyclosporine Concentrations in Renal Transplant Recipients. Pharmacogenomics 18:16, pages 1503-1513.
Read now
Read now
Adrien Flahault, Dany Anglicheau, Marie-Anne Loriot, Eric Thervet & Nicolas Pallet. (2017) Clinical Impact of the CYP3A5 6986A>G Allelic Variant on Kidney Transplantation Outcomes. Pharmacogenomics 18:2, pages 165-173.
Read now
Read now
Christian Lacks Lino Cardenas, Joanna Bourgine, Christelle Cauffiez, Delphine Allorge, Jean Marc Lo-Guidice, Frank Broly & Dany Chevalier. (2010) Genetic polymorphisms of Glycine N-acyltransferase (GLYAT) in a French Caucasian population. Xenobiotica 40:12, pages 853-861.
Read now
Read now
Articles from other publishers (32)
Sean P. Harrison, Saphira F. Baumgarten, Maria E. Chollet, Benedicte Stavik, Anindita Bhattacharya, Runar Almaas & Gareth J. Sullivan. (2024) Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform. Journal of Pediatric Gastroenterology and Nutrition.
Crossref
Crossref
Charlotte Kern, Pie Müller, Carlos Chaccour, Matthias E. Liechti, Felix Hammann & Urs Duthaler. (2023) Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes. Malaria Journal 22:1.
Crossref
Crossref
Karola Warzyszyńska, Michał Zawistowski, Edyta Karpeta, Agnieszka Jałbrzykowska & Maciej Kosieradzki. (2023) CYP3A5 Expressor Genotype of the Transplanted Kidney Increases the Risk of Preterm Graft Loss and Acute Rejection. Nephron 147:7, pages 441-450.
Crossref
Crossref
Dmitry Alekseevitch Sychev, Aleksey Vladimirovich Sokolov, Olga Vilorovna Reshetko, Vladimir Petrovich Fisenko, Igor Nikolaevich Sychev, Elena Anatolievna Grishina, Pavel Olegovich Bochkov, Roman Vladimirovich Shevchenko, Sherzod Pardaboevich Abdullaev, Natalia Pavlovna Denisenko, Dmitry Vladimirovich Ivashchenko, Zhannet Alimovna Sozaeva & Anastasia Alekseevna Kachanova. (2022) Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice. Pharmacogenetics and Genomics 32:9, pages 301-307.
Crossref
Crossref
Deepak Ahire, Laken Kruger, Sheena Sharma, Vijaya Saradhi Mettu, Abdul Basit & Bhagwat Prasad. (2022) Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine. Pharmacological Reviews 74:3, pages 771-798.
Crossref
Crossref
Rémi Lenain, Mehdi Maanaoui, Aghilès Hamroun, Romain Larrue, Cynthia Van Der Hauwaert, Jean-Baptiste Gibier, Viviane Gnemmi, Sébastien Gomis, Myriam Labalette, Franck Broly, Benjamin Hennart, Nicolas Pottier, Marc Hazzan, Christelle Cauffiez & François Glowacki. (2021) Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study. Journal of Personalized Medicine 11:10, pages 1002.
Crossref
Crossref
Eleni Aklillu, Alimuddin Zumla, Abiy Habtewold, Wondwossen Amogne, Eyasu Makonnen, Getnet Yimer, Jürgen Burhenne & Ulf Diczfalusy. (2020) Early or deferred initiation of efavirenz during rifampicin‐based TB therapy has no significant effect on CYP3A induction in TB‐HIV infected patients. British Journal of Pharmacology 178:16, pages 3294-3308.
Crossref
Crossref
Carlos Galaviz-Hernández, Blanca P. Lazalde-Ramos, Ismael Lares-Assef, Alejo Macías-Salas, Margarita A. Ortega-Chavez, Héctor Rangel-Villalobos & Martha Sosa-Macías. (2020) Influence of Genetic Admixture Components on CYP3A5*3 Allele-Associated Hypertension in Amerindian Populations From Northwest Mexico. Frontiers in Pharmacology 11.
Crossref
Crossref
Haroon Khan, Hammad Ullah, Rosa Tundis, Tarun Belwal, Hari Prasad Devkota, Maria Daglia, Zafer Cetin, Eyup Ilker Saygili, Maria da Graça Campos, Esra Capanoglu, Ming Du, Parsa Dar & Jianbo Xiao. (2020) Dietary Flavonoids in the Management of Huntington’s Disease: Mechanism and Clinical Perspective. eFood 1:1, pages 38-52.
Crossref
Crossref
Moataz E. Mohamed, David P. Schladt, Weihua Guan, Baolin Wu, Jessica van Setten, Brendan J. Keating, David Iklé, Rory P. Remmel, Casey R. Dorr, Roslyn B. Mannon, Arthur J. Matas, Ajay K. Israni, William S. Oetting & Pamala A. Jacobson. (2019) Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups. American Journal of Transplantation 19:10, pages 2795-2804.
Crossref
Crossref
A. K. Zastrozhina, S. V. Zaitseva, E. A. Grishina, K. A. Ryzhykova, O. O. Panfeorova, S. Y. Kalenov, O. I. Soboleva, D. A. Sychyov & I. N. Zakharova. (2019) Effect of CYP3A5*3 polymorphism on anti-inflamatory therapy in children with bronchial asthma. Medical Council:11, pages 146-151.
Crossref
Crossref
A. K. Zastrozhina, I. N. Zakharova, D. A. Sychev, E. A. Grishina & K. A. Ryzhikova. (2019) Association of CYP3A5 (6986A>G) gene polymorphism with the effectiveness of anti-inflammatory therapy in children with bronchial asthma. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 64:3, pages 73-77.
Crossref
Crossref
Kevin M. Koch, E. Claire Dees, Shodeinde A. Coker, Nandi J. Reddy, Shelby D. Gainer, Nikita Arya, Andrew P. Beelen & Lionel D. Lewis. (2017) The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer. Cancer Chemotherapy and Pharmacology 80:6, pages 1141-1146.
Crossref
Crossref
Chris Stockmann, Christopher A. Reilly, Bernhard Fassl, Roger Gaedigk, Flory Nkoy, Bryan Stone, Jessica K. Roberts, Derek A. Uchida, J. Steven Leeder, Catherine M.T. Sherwin, Michael G. Spigarelli, Garold S. Yost & Robert M. Ward. (2015) Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone. Journal of Allergy and Clinical Immunology 136:2, pages 505-507.
Crossref
Crossref
O. E. Mustafina, I. A. Tuktarova, D. D. Karimov, R. Sh. Somova & T. R. Nasibullin. (2015) CYP2D6, CYP3A5, and CYP3A4 gene polymorphisms in Russian, Tatar, and Bashkir populations. Russian Journal of Genetics 51:1, pages 98-107.
Crossref
Crossref
Fabiana B. Kohlrausch, Ángel Carracedo & Mara H. Hutz. (2014) Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians. Molecular Biology Reports 41:3, pages 1453-1460.
Crossref
Crossref
Chris Stockmann, Bernhard Fassl, Roger Gaedigk, Flory Nkoy, Derek A. Uchida, Steven Monson, Christopher A. Reilly, J. Steven Leeder, Garold S. Yost & Robert M. Ward. (2013) Fluticasone Propionate Pharmacogenetics: CYP3A4*22 Polymorphism and Pediatric Asthma Control. The Journal of Pediatrics 162:6, pages 1222-1227.e2.
Crossref
Crossref
Ripudaman K Bains, Mirna Kovacevic, Christopher A Plaster, Ayele Tarekegn, Endashaw Bekele, Neil N Bradman & Mark G Thomas. (2013) Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa. BMC Genetics 14:1, pages 34.
Crossref
Crossref
Ripudaman K. Bains. (2013) African variation at Cytochrome P450 genes. Evolution, Medicine, and Public Health 2013:1, pages 118-134.
Crossref
Crossref
Al-Motassem Yousef, Nailya R. Bulatova, William Newman, Nancy Hakooz, Said Ismail, Hisham Qusa, Farah Zahran, Nidaa Anwar Ababneh, Farah Hasan, Imad Zaloom, Ghada Khayat, Rawan Al-Zmili, Randa Naffa & Ola Al-Diab. (2012) Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Molecular Biology Reports 39:10, pages 9423-9433.
Crossref
Crossref
Veronique Michaud, Tamara Bar-Magen, Jacques Turgeon, David Flockhart, Zeruesenay Desta & Mark A. Wainberg. (2012) The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition. Pharmacological Reviews 64:3, pages 803-833.
Crossref
Crossref
Krume Jakovski, Aleksandra Kapedanovska Nestorovska, Nikola Labacevski & Aleksandar J. Dimovski. (2012) Frequency of the most common CYP3A5 polymorphisms in the healthy population of the Republic of Macedonia. Macedonian Pharmaceutical Bulletin 58, pages 25-30.
Crossref
Crossref
Christoph Hiemke, Pierre Baumann & Julia Stingl. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
441
464
.
Christian L. Lino Cardenas, Nicolas Renault, Amaury Farce, Christelle Cauffiez, Delphine Allorge, Jean-Marc Lo-Guidice, Michel Lhermitte, Philippe Chavatte, Franck Broly & Dany Chevalier. (2011) Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population. Gene 487:1, pages 10-20.
Crossref
Crossref
Manuel Diezi, Andreas Nydegger, Ermindo R. Di Paolo, Henri Kuchler & Maja Beck-Popovic. (2010) Vincristine and Intestinal Pseudo-obstruction in Children. Journal of Pediatric Hematology/Oncology 32:4, pages e126-e130.
Crossref
Crossref
Walter E. Müller, Christoph Hiemke, Pierre Baumann, Bruno Pfuhlmann & Jürgen Deckert. 2010. Grundlagen der Neuro-Psychopharmakologie. Grundlagen der Neuro-Psychopharmakologie
289
351
.
Dominique Levêque, Raoul Santucci, Julien Pavillet, Raoul Herbrecht & Jean Pierre Bergerat. (2009) Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine. Pharmacy World & Science 31:6, pages 619-621.
Crossref
Crossref
Eliecer Coto & Beatriz Tavira. (2009) Pharmacogenetics of Calcineurin Inhibitors in Renal Transplantation. Transplantation 88:3S, pages S62-S67.
Crossref
Crossref
S. Y. Park, Y. S. Kang, M. S. Jeong, H. K. Yoon & K. O. Han. (2008) Frequencies of CYP3A5 genotypes and haplotypes in a Korean population. Journal of Clinical Pharmacy and Therapeutics 33:1, pages 61-65.
Crossref
Crossref
Elizabeth J Phillips & Simon A Mallal. (2008) Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Current Opinion in Infectious Diseases 21:1, pages 16-24.
Crossref
Crossref
Christoph Hiemke & Pierre Baumann. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
375
397
.
E D Kharasch, A Walker, N Isoherranen, C Hoffer, P Sheffels, K Thummel, D Whittington & D Ensign. (2007) Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam. Clinical Pharmacology & Therapeutics 82:4, pages 410-426.
Crossref
Crossref